UK watchdog says it may accept remedies in $35 billion Synopsys-Ansys deal

(Reuters) - The UK's competition regulator said on Wednesday that it might accept remedies offered by the parties in chip design software maker Synopsys (NASDAQ:SNPS )' $35 billion acquisition of Ansys (NASDAQ:ANSS ).

The Competition and Markets Authority said the undertakings offered on Dec. 31 included the divestment of Ansys' power consumption analysis product for digital chips and Synopsys' sale of its global optics and photonics software business.

Source: Investing.com